Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H24N2O2 |
Molecular Weight | 324.4168 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@H](O)C3=C4C=C(OC)C=CC4=NC=C3
InChI
InChIKey=LOUPRKONTZGTKE-WZBLMQSHSA-N
InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19-,20+/m0/s1
Molecular Formula | C20H24N2O2 |
Molecular Weight | 324.4168 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:13:35 UTC 2023
by
admin
on
Fri Dec 15 15:13:35 UTC 2023
|
Record UNII |
A7V27PHC7A
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C271
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
||
|
WHO-ATC |
P01BC01
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
||
|
CFR |
21 CFR 862.3750
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
||
|
CFR |
21 CFR 310.546
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
||
|
DSLD |
2588 (Number of products:3)
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
||
|
CFR |
21 CFR 172.575
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
||
|
CFR |
21 CFR 310.547
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
||
|
NDF-RT |
N0000175482
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
||
|
WHO-VATC |
QM09AA72
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.5.3.1
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
||
|
WHO-ATC |
M09AA72
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
||
|
LIVERTOX |
NBK548596
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
15854
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
137041
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
52251
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
A7V27PHC7A
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
4523
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
A7V27PHC7A
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
D011803
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
Quinine
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
2510
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
CHEMBL170
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
192949
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
QUININE
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
100000078599
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
205-003-2
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
2501
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
9071
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | RxNorm | ||
|
130-95-0
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
C794
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
DB00468
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
m9447
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB15084MIG
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
3034034
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY | |||
|
DTXSID0044280
Created by
admin on Fri Dec 15 15:13:35 UTC 2023 , Edited by admin on Fri Dec 15 15:13:35 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
TRANSPORTER -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
BINDER->LIGAND |
BINDING
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
TRANSPORTER -> INHIBITOR | |||
|
TRANSPORTER -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
MINOR
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE -> PARENT |
URINE
|
||
|
METABOLITE LESS ACTIVE -> PARENT |
MAJOR
PLASMA; URINE
|
||
|
METABOLITE LESS ACTIVE -> PARENT |
Quinine is metabolized almost exclusively via hepatic oxidative cytochrome P450 (CYP) pathways. In vitro studies using human liver microsomes and recombinant P450 enzymes have shown that quinine is metabolized mainly by CYP3A4. Depending on the in vitro experimental conditions, other enzymes, including CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP2E1 were shown to have some role in the metabolism of quinine.
|
||
|
METABOLITE -> PARENT |
MINOR
PLASMA; URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
INTERNATIONAL PHARMACOPEIA
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||